To the EMA Executive DirectorTo the members of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)Cc: European Commission Brussels, 24 January 2023 Dear Chair and members of the MSSG, We are writing to you because we believe that the...
While the COVID-19 pandemic has brought access and affordability of medicines to the spotlight, it has also underscored the need for more balance, transparency, and accountability in the pharmaceutical sector. The 2022 Access to Medicines Forum coincides with the...
More than 32 million adults and 170,000 children live with a form of diabetes in the EU. Although 14 types of diabetes have been identified so far, the most common are Type 1 and Type 2. Most cases of Type 2 Diabetes are preventable. Yet, Type 1 and other forms are...
5th EPHA Universal Access and Affordable Medicines Forum 5 December 2022 09:00 - 17:00 Scotland House Brussels The access to medicines (A2M) Forum is a yearly event organised by EPHA to foster a meaningful and inclusive dialogue on access to medicines and...
By Benedetta Baldini, Health Policy Lead at the European Social Insurance Platform (ESIP) Solidarity. This defining principle of social protection across Europe is what makes our welfare systems citizen-centred and society-conscious. Applied to the healthcare sector,...
